The Department of Health and Human Services, Administration on Aging. Projected future growth of the older population. http://www.aoa.gov/aoaroot/aging_statistics/future_growth/future_growth.aspx#age. Accessed July 20, 2016.
Caterino JM, Valasek T, Werman HA. Identification of an age cutoff for increased mortality in patients with elderly trauma. Am J Emerg Med. 2010;28:151–8.
Holliday R. Aging is no longer an unsolved problem in biology. Ann N Y Acad Sci. 2006;1067:1–9.
••Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007;447:725–9. This paper discusses the DNA repair mechanisms with aging in the hematopoietic system.
Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011;66(2):202–13.
Ishikawa N, Nakamura K, Izumiyama-Shimomura N, Aida J, Matsuda Y, Arai T, et al. Changes of telomere status with aging: an update. Gerontol Int. 2016;16 Suppl 1:30–42.
••Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C, et al. Danazol treatment for telomere diseases. N Engl J Med. 2016;374:1922–31. This paper highlights the importance of danazol as a potential treatment for disease associated with aging.
Shalev I, Belsky J. Early-life stress and reproductive cost: a two -hit developmental model of accelerated aging? Med Hypotheses. 2016;90:41–7.
•Rundberg Nilsson A, Soneji S, Adolfsson S, Bryder D, Pronk CJ. Human and murine hematopoietic stem cell aging is associated with functional impairments and intrinsic megakaryocytic/erythroid bias. PLoS One. 2016;11(7):e0158369. This paper describes changes in balance in downstream erythroid potentiation with aging.
Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005;102:9194–9.
Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of aging. J Pathol. 2007;211:144–56.
Prince M et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.
Foster CM, Picklesimer ME, Mulligan NW, Giovanello KS. The effect of age on relational encoding as revealed by hippocampal functional connectivity. Neurobiol Learn Mem. 2016;134 Pt A:5–14.
Filippini F, Hayek T, Aviram M, Keidar S, Rodella LF, Coleman R, et al. Apolipoprotein E and its role in aging and survival. Exp Gerontol. 2010;45(2):149–57.
Neuner SM, Garfinkel BP, Wilmott LA, Ignatowska-Jankowska BM, Citri A, Orly J, et al. Systems genetics identifies Hp1bp3 as a novel modulator of cognitive aging. Neurobiol Aging. 2016;46:58–67.
•Jackson PA, Pialoux V, Corbett D, Drogos L, Erickson KI, Eskes GA, et al. Promoting brain health through exercise and diet in older adults: a physiological perspective. J Physiol. 2016;594(16):4485–98. This paper describes preventative measures to belay the effects of aging on the brain.
Tyndall AV, Davenport MH, Wilson BJ, Burek GM, Arsenault-Lapierre G, Haley E, et al. The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults. BMC Geriatr. 2013;13:21.
McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;4:CD004034.
Koga S, Dickson DW, Bieniek KF. Chronic traumatic encephalopathy pathology in multiple system atrophy. J Neuropathol Exp Neurol. 2016;75:963–70.
Zalewski CK. Aging of the human vestibular system. Semin Hear. 2015;36(3):175–96.
Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology. 1987;37(3):371–8.
Parnes LS, McClure JA. Free-floating endolymph particles: a new operative finding during posterior semicircular canal occlusion. Laryngoscope. 1992;102(9):988–92.
Rauch SD, Velazquez-Villaseñor L, Dimitri PS, Merchant SN. Decreasing hair cell counts in aging humans. Ann N Y Acad Sci. 2001;942:220–7.
Iwasaki S, Smulders YE, Burgess AM, McGarvie LA, Macdougall HG, Halmagyi GM, et al. Ocular vestibular evoked myogenic potentials to bone conducted vibration of the midline forehead at Fz in healthy subjects. Clin Neurophysiol. 2008;119(9):2135–47.
Agrawal Y, Zuniga MG, Davalos-Bichara M, Schubert MC, Walston JD, Hughes J, et al. Decline in semicircular canal and otolith function with age. Otol Neurotol. 2012;33(5):832–9.
Mattace-Raso FU, van den Meiracker AH, Bos WJ, van der Cammen TJ, Westerhof BE, Elias-Smale S, et al. Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study. J Hypertens. 2007;25:1421–6.
Swierblewska E, Hering D, Kara T, Kunicka K, Kruszewski P, Bieniaszewski L, et al. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens. 2010;28:979–84.
Lind L, Berglund L, Larsson A, Sundström J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation. 2011;123:1545–51.
•Parikh JD, Hollingsworth KG, Wallace D, Blamire AM, MacGowan GA. Normal age-related changes in left ventricular function: role of afterload and subendocardial dysfunction. Int J Cardiol. 2016;223:306–12. This paper describes subendocardial dysfunction and changes in cardiac output in aging adults.
Forman DE, Alexander KP. Frailty: a vital sign for older adults with cardiovascular disease. Can J Cardiol. 2016; (16)30127-1.
Anton SD, Woods AJ, Ashizawac T, et al. Successful aging: advancing the science of physical independence in older adults. Ageing Res Rev. 2015;24(9):304–27.
Dawson A, Dennison E. Measuring the musculoskeletal aging phenotype. Maturitas 2016.
Goodman CA, Hornberger TA, Robling AG. Bone and skeletal muscle: key players in mechanotransduction and potential overlapping mechanisms. Bone. 2015;80:24–36.
Budui SL, Rossi AP, Zamboni M. The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab. 2015;12(91):22–6.
Reilly BD, Franklin CE. Prevention of muscle wasting and osteoporosis: the value of examining novel animal models. J Exp Biol. 2016;219:2582–95.
Talbert EE, Smuder AJ, Min K, Kwon OS, Szeto HH, Powers SK. Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant. J Appl Physiol. 2013;115:529–38.
O’Connor RS, Pavlath GK, McCarthy JJ, Esser KA. Last word on point: counterpoint: satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. J Appl Physiol. 2007;103:1107.
••Bruusgaard JC, Johansen IB, Egner IM, Rana ZA, Gundersen K. Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining. Proc Natl Acad Sci U S A. 2010;107:15111–6. This paper describes a new paradigm for our understanding of muscle hypertrophy and atrophy.
Gundersen K. Muscle memory and a new cellular model for muscle atrophy and hypertrophy. J Exp Biol. 2016;219:235–42.
Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005;37:1974–84.
Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14(1):58–74.
Levine S et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358:1327–35.
Helliwell TR et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol. 1998;24:507–17.
•Sheetz KH, Waits SA, Terjimanian MN, et al. Cost of major surgery in the sarcopenic patient. J Am Coll Surg. 2013;217(5):813–8. This paper describes the clinical effects of sarcopenia on patients requiring surgery in old age.
Please provide complete bibliographic details for this reference
Ibebunjo C et al. Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol. 2013;33:194–212.
Brill KT et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab. 2002;87:5649–57.
Siriett V et al. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther. 2007;15:1463–70.
Szulc P, Delmas PD. Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition: the prospective MINOS study. Osteoporos Int. 2007;18(4):495–503.
Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015;37(8):1837–50.
Santos A, Bakker AD, Klein-Nulend J. The role of osteocytes in bone mechanotransduction. Osteoporos Int. 2009;20:1027–31.
Baron R, Rawadi G. Minireview: targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007;148:2635–43.
Spatz JM, Ellman R, Cloutier AM, et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res. 2013;28:865–74.
Masi L. Crosstalk between the brain and bone. Clin Cases Miner Bone Metab. 2012;9:13–6.
•Gómez-Cabello A, Ara I, González-Agüero A, Casajús JA, Vicente-Rodríguez G. Effects of training on bone mass in older adults: a systematic review. Sports Med. 2012;42(4):301–25. This paper describes preventative measures to belay the effects of aging on the musculoskeletal system.
English KL, Loehr JA, Lee SMC, Smith SM. Early-phase musculoskeletal adaptations to different levels of eccentric resistance after 8 weeks of lower body training. Eur J Appl Physiol. 2014;114:2263–80.